They should be having blood draws for comprehensive metabolic profiles beyond just looking at labs for diabetes, he says
Guo Y, Yang Y, Mao Q, Liu H, Wang T, Sun F, et al
Whether short-term use is worthwhile depends less on the medication itself and more on what happens after it is discontinued
Purpose-built for physicians GLP-1 drugs may extend life, graft survival for kidney transplant recipients with diabetes Key takeaways: Kidney transplant recipients with type 2 diabetes prescribed GLP-1 receptor agonists had 31% lower mortality vs
Wrinkles that form from elastin loss tend to be deeper and more permanent than those from collagen decline alone
Oz declined to speculate on the number with reporters